LifeStance Health Group, Inc.

For the period ended Mar 31, 2025. Filed May 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

LFST$13.77+2.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Balance Sheets

(In thousands, except for par value)

	March 31, 2025	December 31, 2024
CURRENT ASSETS
Cash and cash equivalents	$134,336	$154,571
Patient accounts receivable, net	140,370	131,802
Prepaid expenses and other current assets	29,927	26,137
Total current assets	304,633	312,510
NONCURRENT ASSETS
Property and equipment, net	163,718	166,041
Right-of-use assets	148,068	147,878
Intangible assets, net	187,333	190,799
Goodwill	1,293,346	1,293,346
Other noncurrent assets	7,574	7,724
Total noncurrent assets	1,800,039	1,805,788
Total assets	$2,104,672	$2,118,298
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable	$7,415	$7,242
Accrued payroll expenses	99,922	117,461
Other accrued expenses	43,245	46,942
Operating lease liabilities, current	47,301	49,449
Other current liabilities	9,502	7,792
Total current liabilities	207,385	228,886
NONCURRENT LIABILITIES
Long-term debt, net	276,322	279,790
Operating lease liabilities, noncurrent	149,391	148,699
Deferred tax liability, net	14,221	14,329
Other noncurrent liabilities	254	309
Total noncurrent liabilities	440,188	443,127
Total liabilities	$647,573	$672,013
COMMITMENTS AND CONTINGENCIES (see Note 11)
STOCKHOLDERS’ EQUITY
Preferred stock – par value $0.01 per share; 25,000 shares authorized as of March 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024	—	—
Common stock – par value $0.01 per share; 800,000 shares authorized as of March 31, 2025 and December 31, 2024; 388,826 and 382,735 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	3,888	3,827
Additional paid-in capital	2,270,179	2,259,818
Accumulated other comprehensive income	612	929
Accumulated deficit	(817,580)	(818,289)
Total stockholders' equity	1,457,099	1,446,285
Total liabilities and stockholders’ equity	$2,104,672	$2,118,298

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.